Aqr Capital Management LLC Iveric Bio, Inc. Transaction History

Aqr Capital Management LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$26.24 - $39.63 $485,991 - $733,987	18,521 Added 87.42%	39,707 $1.56 Million
Q1 2023 May 15, 2023	BUY	$18.67 - $24.56 $60,080 - $79,034	3,218 Added 17.91%	21,186 $515,000
Q4 2022 Feb 14, 2023	SELL	$17.24 - $23.95 $13,895 - $19,303	-806 Reduced 4.29%	17,968 $384,000
Q3 2022 Nov 14, 2022	SELL	$9.4 - $18.59 $75,641 - $149,593	-8,047 Reduced 30.0%	18,774 $337,000
Q2 2022 Aug 15, 2022	SELL	$9.12 - $18.9 $5,462 - $11,321	-599 Reduced 2.18%	26,821 $258,000
Q1 2022 May 16, 2022	SELL	$12.15 - $16.83 $694,846 - $962,490	-57,189 Reduced 67.59%	27,420 $461,000
Q4 2021 Feb 14, 2022	BUY	$13.83 - $18.78 $638,268 - $866,715	46,151 Added 120.0%	84,609 $1.42 Million
Q3 2021 Nov 15, 2021	BUY	$7.07 - $17.5 $271,898 - $673,015	38,458 New	38,458 $625,000
Q2 2021 Aug 16, 2021	SELL	$5.69 - $7.17 $214,268 - $270,000	-37,657 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$5.08 - $6.89 $675,960 - $916,804	-133,063 Reduced 77.94%	37,657 $233,000
Q4 2020 Feb 16, 2021	BUY	$5.65 - $7.66 $225,932 - $306,308	39,988 Added 30.59%	170,720 $1.18 Million
Q3 2020 Nov 16, 2020	BUY	$4.01 - $6.29 $524,235 - $822,304	130,732 New	130,732 $737,000

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aqr Capital Management LLC with notifications on news.